• Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.

  • Apr 30 2024
  • Length: 15 mins
  • Podcast
Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D. cover art

Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.

Listen for free

View show details

  • Summary

  • David S. Viswanatha, M.D., explains how Mayo Clinic Laboratories' new assay provides rapid, definitive diagnosis of VEXAS, a recently identified syndrome affecting older men. Early diagnosis is key to managing the condition, which severely impacts multiple organs and blood.


    (00:31)
    Could you please provide a little bit about yourself and your background?

    (01:30)
    Would you please share a brief overview of the UBA1Q assay?

    (02:13)
    Would you provide an overview of VEXAS syndrome?

    (05:30)
    When is this testing recommended during care for patients who have a suspected inflammatory condition or VEXAS syndrome?

    (06:38)
    What advantage does this assay provide over other methodologies?

    (10:13)
    Could you share further why diagnosis is so important for these patients?


    (12:40)
    Is there anything else you'd like to comment about the assay?
    Show More Show Less
Show More Show Less

What listeners say about Assay provides quick diagnosis of VEXAS syndrome: David S. Viswanatha, M.D.

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.